<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00181285</url>
  </required_header>
  <id_info>
    <org_study_id>14831A</org_study_id>
    <nct_id>NCT00181285</nct_id>
  </id_info>
  <brief_title>Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)</brief_title>
  <official_title>Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hill-Rom</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study was to evaluate the use of high frequency chest wall oscillation
      (HFCWO) early in the treatment of adults hospitalized for acute asthma or chronic obstructive
      pulmonary disease (COPD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute asthma and chronic obstructive pulmonary disease (COPD) are exceedingly common, which
      together account for nearly 1 million hospitalizations each year in the United States alone.
      Beta agonists, anticholinergics, and corticosteroids delivered in aerosolized forms (via
      respiratory inhalers or nebulization) are recommended in the treatment of acute asthma and
      COPD. These medications rely on deposition into distal airspaces to suppress airway
      inflammation or promote bronchodilation. Unfortunately, excessive mucous production and
      impaired airway mucociliary clearance can lead to airway plugging, and thereby reduce the
      deposition of and response to aerosolized medications. These considerations highlight the
      need for therapies that clear airways of mucus in the acute management of asthma and COPD.
      High frequency chest wall oscillation (HFCWO) creates high velocity, low amplitude
      oscillatory airflows when applied through a pneumatic vest worn over the thorax, and is used
      for airway mucus clearance in patients with cystic fibrosis, bronchiectasis, and
      neuromuscular disorders.

      This was a randomized, multi-center, double-masked phase II clinical trial of active or sham
      treatment initiated within 24 hours of hospital admission for acute asthma or COPD at four
      academic medical centers. Patients received active or sham treatment for 15 minutes three
      times a day for four treatments. Medical management was standardized across groups. The
      primary outcomes were patient adherence to therapy after four treatments (minutes used/60
      minutes prescribed) and satisfaction. Secondary outcomes included change in Borg dyspnea
      score (â‰¥ 1 unit indicates a clinically significant change), spontaneously expectorated sputum
      volume, and forced expired volume in 1 second.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2003</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Adherence to High Frequency Chest Wall Oscillation</measure>
    <time_frame>After four treatments of 15 minutes each</time_frame>
    <description>Patient adherence to therapy after four treatments.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Who Considered the Pneumatic Vest Convenient to Use</measure>
    <time_frame>After four treatments of 15 minutes each</time_frame>
    <description>The study vest was convenient to use.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Asthma</condition>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <condition>Undifferentiated Asthma/COPD</condition>
  <arm_group>
    <arm_group_label>Sham high frequency chest wall oscillation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham high frequency chest wall oscillation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active high frequency chest wall oscillation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active high frequency chest wall oscillation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High Frequency Chest Wall Oscillator</intervention_name>
    <description>High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax</description>
    <arm_group_label>Active high frequency chest wall oscillation</arm_group_label>
    <arm_group_label>Sham high frequency chest wall oscillation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years and older

          -  Admission to the inpatient medical service

          -  Physician-diagnosed asthma or asthma/COPD or COPD exacerbation.

          -  Evidence of airflow obstruction on spirometry

        Exclusion Criteria:

          -  More than 24 hours since admission to the inpatient medical service

          -  Admission to an intensive care unit

          -  Hospital discharge planned within the next 24 hours

          -  Other chronic respiratory disease (e.g., sarcoidosis, idiopathic pulmonary fibrosis)

          -  Chest wall abnormalities (e.g., severe kyphoscoliosis) that precludes using the vest

          -  Chest wall or abdominal trauma/surgery in the past 6 weeks that precludes using the
             vest

          -  Physician declines to provide consent

          -  Patient unable (e.g., history of cognitive impairment, unable to understand English)
             or declines to provide consent

          -  Previous participant in this study

          -  Corticosteroid therapy (prednisone &gt;0 mg/d equivalent) for &gt;1 week prior to admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerry A Krishnan, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mercy Hospital and Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60616</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>September 15, 2005</study_first_submitted>
  <study_first_submitted_qc>September 15, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <results_first_submitted>May 12, 2017</results_first_submitted>
  <results_first_submitted_qc>July 10, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">August 7, 2018</results_first_posted>
  <last_update_submitted>August 6, 2018</last_update_submitted>
  <last_update_submitted_qc>August 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sham High Frequency Chest Wall Oscillation</title>
          <description>Sham high frequency chest wall oscillation.
High Frequency Chest Wall Oscillator: High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax</description>
        </group>
        <group group_id="P2">
          <title>Active High Frequency Chest Wall Oscillation</title>
          <description>High frequency chest wall oscillation
High Frequency Chest Wall Oscillator: High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sham High Frequency Chest Wall Oscillation</title>
          <description>Sham high frequency chest wall oscillation
High Frequency Chest Wall Oscillator: High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax</description>
        </group>
        <group group_id="B2">
          <title>Active High Frequency Chest Wall Oscillation</title>
          <description>High frequency chest wall oscillation
High Frequency Chest Wall Oscillator: High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="52"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.4" lower_limit="43.9" upper_limit="60.7"/>
                    <measurement group_id="B2" value="46.5" lower_limit="38.6" upper_limit="52.8"/>
                    <measurement group_id="B3" value="48.5" lower_limit="41.1" upper_limit="55.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Sex/Gender was not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patient Adherence to High Frequency Chest Wall Oscillation</title>
        <description>Patient adherence to therapy after four treatments.</description>
        <time_frame>After four treatments of 15 minutes each</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham High Frequency Chest Wall Oscillation</title>
            <description>Sham high frequency chest wall oscillation
High Frequency Chest Wall Oscillator: High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax</description>
          </group>
          <group group_id="O2">
            <title>Active High Frequency Chest Wall Oscillation</title>
            <description>Active high frequency chest wall oscillation
High Frequency Chest Wall Oscillator: High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Adherence to High Frequency Chest Wall Oscillation</title>
          <description>Patient adherence to therapy after four treatments.</description>
          <units>Percent of 60 minutes prescribed</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" spread="18.7"/>
                    <measurement group_id="O2" value="91" spread="21.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Considered the Pneumatic Vest Convenient to Use</title>
        <description>The study vest was convenient to use.</description>
        <time_frame>After four treatments of 15 minutes each</time_frame>
        <population>1 participant in the Sham group and 1 participant in the Active group had missing data for the question regarding the convenience of the pneumatic vest, therefore these participants were not included in the number analyzed for the outcome measure data table below.</population>
        <group_list>
          <group group_id="O1">
            <title>Sham High Frequency Chest Wall Oscillation</title>
            <description>Sham high frequency chest wall oscillation
High Frequency Chest Wall Oscillator: High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax</description>
          </group>
          <group group_id="O2">
            <title>Active High Frequency Chest Wall Oscillation</title>
            <description>Active high frequency chest wall oscillation
High Frequency Chest Wall Oscillator: High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Considered the Pneumatic Vest Convenient to Use</title>
          <description>The study vest was convenient to use.</description>
          <population>1 participant in the Sham group and 1 participant in the Active group had missing data for the question regarding the convenience of the pneumatic vest, therefore these participants were not included in the number analyzed for the outcome measure data table below.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Sham High Frequency Chest Wall Oscillation</title>
          <description>Sham high frequency chest wall oscillation
High Frequency Chest Wall Oscillator: High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax</description>
        </group>
        <group group_id="E2">
          <title>Active High Frequency Chest Wall Oscillation</title>
          <description>Active high frequency chest wall oscillation
High Frequency Chest Wall Oscillator: High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jerry A. Krishnan</name_or_title>
      <organization>University of Illinois at Chicago</organization>
      <phone>312-413-0637</phone>
      <email>jakris@uic.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

